Allscripts Healthcare Solutions, Inc. (MDRX) financial statements (2021 and earlier)

Company profile

Business Address 222 MERCHANDISE MART PLAZA
CHICAGO, IL 60654
State of Incorp. DE
Fiscal Year End December 31
SIC 7373 - Computer Integrated Systems Design (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments130129139137174112136
Cash and cash equivalents130129139137174112136
Restricted cash and investments899111185
Receivables460427428458465520522
Prepaid expense146      
Contract with customer, asset966675956672 
Other current assets2      
Other undisclosed current assets 143152133142132193
Total current assets:841774804834859844856
Noncurrent Assets
Operating lease, right-of-use asset98104  
Property, plant and equipment8897106116122160161
Long-term investments and receivables44453938372223
Long-term investments44453938372223
Intangible assets, net (including goodwill), including:1,4141,7851,7851,7891,8053,0822,947
Goodwill1,3621,3871,3821,3741,3742,2082,108
Intangible assets, net (excluding goodwill) 398403415431874839
Other undisclosed intangible assets, net (including goodwill)52      
Prepaid expense33   33  
Contract with customer, asset, net6810298727253 
Deferred costs36   21  
Other noncurrent assets125127115110109135115
Other undisclosed noncurrent assets459196288284125223253
Total noncurrent assets:2,3642,4562,4312,4082,3233,6743,498
TOTAL ASSETS:3,2063,2303,2353,2423,1814,5184,354
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities443421401251309355344
Accounts payable104102918173127122
Accrued liabilities271262257109106120113
Employee-related liabilities69585462100108109
Taxes payable    30  
Deferred revenue380373  
Debt3883832221212929
Disposal group, including discontinued operation    1  
Deferred revenue and credits531
Contract with customer, liability432504467507 
Other undisclosed current liabilities  2524 43
Total current liabilities:1,2111,177880800798894907
Noncurrent Liabilities
Long-term debt and lease obligation6466558237666481,007990
Long-term debt, excluding current maturities5515558237666481,002983
Finance lease, liability00  
Capital lease obligations157
Operating lease, liability95100  
Liabilities, other than long-term debt4361124125155242230
Deferred revenue and credits21
Deferred revenue1212  
Contract with customer, liability13131622 
Deferred tax liabilities, net575858124129
Other liabilities30495454819680
Other undisclosed noncurrent liabilities21559395 791629
Total noncurrent liabilities:7107721,0399878032,0391,849
Total liabilities:1,9211,9491,9191,7861,6012,9332,756
Temporary equity, carrying amount     468456
Stockholders' equity
Stockholders' equity attributable to parent1,2851,2811,3161,4561,5511,0871,112
Common stock3333333
Treasury stock, value(571)(562)(525)(526)(461)(424)(425)
Additional paid in capital1,9071,8761,8681,8581,8811,7651,767
Accumulated other comprehensive loss(4)(6)(5)(5)(5)(5)(4)
Retained earnings (accumulated deficit)(49)(30)(25)125133(251)(228)
Stockholders' equity attributable to noncontrolling interest    292929
Total stockholders' equity:1,2851,2811,3161,4561,5801,1171,142
TOTAL LIABILITIES AND EQUITY:3,2063,2303,2353,2423,1814,5184,354

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues451444444432188522526
Revenue, net189
Cost of revenue(271)(269)(260)(258)(116)(304)(313)
Cost of goods and services sold(29)(29)(29)(28)(2)(35)(198)
Gross profit:18017518417473218213
Operating expenses(151)(172)(179)(171)(65)(216)(271)
Other undisclosed operating loss(64)   (40)  
Operating income (loss):(35)353(32)2(59)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
51(145)11(1)(0)
Interest and debt expense(12)(11)(10)(10)30(29)(26)
Loss from continuing operations before equity method investments, income taxes:(42)(7)(151)(7)(2)(27)(85)
Income (loss) from equity method investments000(0)(0)(0)1
Other undisclosed income (loss) from continuing operations before income taxes(2)  1  163
Income (loss) from continuing operations before income taxes:(44)(6)(150)(6)(2)(28)79
Income tax expense (benefit)2511(2)(3)4(4)
Income (loss) from continuing operations:(19)(6)(150)(8)(6)(24)75
Income (loss) from discontinued operations    391 (1)
Net income (loss):(19)(6)(150)(8)386(24)74
Net income attributable to noncontrolling interest   0103
Net income (loss) attributable to parent:(19)(6)(150)(8)387(24)77
Preferred stock dividends and other adjustments    (12)(12)(12)
Net income (loss) available to common stockholders, diluted:(19)(6)(150)(8)375(36)65

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):(19)(6)(150)(8)386(24)74
Other comprehensive income (loss)1(1)(0)10(1)(2)
Comprehensive income (loss):(18)(7)(150)(7)386(25)72
Comprehensive income, net of tax, attributable to noncontrolling interest   0103
Comprehensive income (loss), net of tax, attributable to parent:(18)(7)(150)(7)387(25)75

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: